Know Cancer

or
forgot password
  • cancer clinical trials in aurora, CO

  • A Study of Volociximab in Metastatic Melanoma
    Site Reference ID/Investigator# 70375
    Aurora, Colorado 80045
    Stage IV Melanoma
    Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
    GSK Investigational Site
    Aurora, Colorado 80012
    Human Papillomavirus Type-16/-18 Infection, Papillomavirus Vaccines, Cervical Neoplasia
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Children's Hospital Colorado Center for Cancer and Blood Disorders
    Aurora, Colorado 80045
    Leukemia
    Methylphenidate in Treating Patients With Fatigue Caused by Cancer
    Aurora Presbyterian Hospital
    Aurora, Colorado 80012
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Children's Hospital Colorado
    Aurora, Colorado 80045
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    Children's Hospital Colorado
    Aurora, Colorado 80045
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Thyroid Neoplasms
    TroVax Renal Immunotherapy Survival Trial
    UCHSC
    Aurora, Colorado 80045
    Clear Cell Renal Carcinoma
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Aurora Presbyterian Hospital
    Aurora, Colorado 80012
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
    University of Colorado Dept. of Univ. of Colorado
    Aurora, Colorado 80045
    Metastatic Hormone Refractory Prostate Cancer
    A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan
    University of Colorado, Denver
    Aurora, Colorado 80045
    Neoplasms
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Advanced HIV Infection
    A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Carcinoma, Islet Cell, Carcinoma, Pancreas
    Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
    University of Colorado at Denver and Health Science Center
    Aurora, Colorado 80045
    Esophageal Adenocarcinoma
    A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction
    Univ. of Colorado Health Sciences
    Aurora, Colorado 80010
    Cholestasis, Extrahepatic
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Neoplasms
    A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies
    Site Reference ID/Investigator# 3755
    Aurora, Colorado 80045-0510
    Small Cell Lung Cancer, Small Cell Lung Carcinoma
    Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
    Children's Hospital Colorado
    Aurora, Colorado 80045
    Adrenocortical Carcinoma, Localized Resectable Neuroblastoma, Precancerous Condition
    Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)
    University of Colorado Health Sciences Center/Anschutz Cancer Pavilion
    Aurora, Colorado 80010
    Leukemia, Myeloid, Chronic
    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Colorectal Neoplasms
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Children's Hospital Colorado Center for Cancer and Blood Disorders
    Aurora, Colorado 80045
    Leukemia
    Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma
    University of Colorado Health Sciences Center/Anschutz Cancer Pavillion
    Aurora, Colorado 80010
    Cutaneous T-Cell Lymphoma
    Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies
    University of Colorado, Anschutz Cancer Pavillion
    Aurora, Colorado 80010
    Progressive Metastatic Malignancies
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Colorado Gynecologic Oncology Group, PC
    Aurora, Colorado 80010
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Colorado Gynecologic Oncology Group, PC
    Aurora, Colorado 80010
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
    Univeristy of Colorado Health Cancer Center
    Aurora, Colorado 80010
    Leukemia, Myeloid
    Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
    Site Reference ID/Investigator# 5646
    Aurora, Colorado 80045-0510
    Non-Small Cell Lung Cancer (NSCLC)
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Anschutz Cancer Pavillion University of Colorado
    Aurora, Colorado 80010
    Melanoma
    Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
    Children's Hospital Center for Cancer and Blood Disorders
    Aurora, Colorado 80045
    Leukemia
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    University of Colorado Hospital Anschutz Outpatient Pavilioin
    Aurora, Colorado
    Multiple Sclerosis, Relapsing-Remitting
    Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
    GSK Investigational Site
    Aurora, Colorado 80012
    Neoplasms, Breast
    Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
    University of Colorado Health Science Center
    Aurora, Colorado 80010-0510
    Advanced Solid Tumors, Non-Hodgkin's Lymphoma
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Colorectal Neoplasms, Neoplasms
    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Colorectal Neoplasms
    Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients
    UCHSC
    Aurora, Colorado 80045
    Advanced Cancer
    A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
    GSK Investigational Site
    Aurora, Colorado 80012
    Advanced Solid Tumours, Cancer, Lung Cancer, Non-Small Cell
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    University of Colorado U of Colorado Cancer Center
    Aurora, Colorado 80045
    Multiple Myeloma
    Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
    Children's Hospital for Cancer & Blood Disorders
    Aurora, Colorado 80045
    Osteosarcoma, Leukemia, Lymphoma
    Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
    The Medical Center of Aurora
    Aurora, Colorado 80012
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    A Study of ARRY-380 in Patients With Advanced HER2+ Cancer
    The University of Colorado Cancer Center
    Aurora, Colorado
    Cancer
    Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
    University of Colorado Health Sciences Center/Anschutz Pavillion
    Aurora, Colorado 12801
    Metastatic Renal Cell Cancer
    Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Head and Neck Neoplasm, Prostatic Neoplasm, Pancreatic Neoplasm
    Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous Cell
    Pregabalin in Treating Women With Hot Flashes
    Aurora Presbyterian Hospital
    Aurora, Colorado 80012
    Breast Cancer, Hot Flashes
    A Study of PF-04217903 in Patients With Advanced Cancer
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Neoplasms
    A Phase 1 Dose Escalation Study of IPI-493
    Univeristy of Colorado Health Science Center
    Aurora, Colorado 80045
    Advanced Malignancies
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Diabetes Mellitus
    Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
    University of Colorado Cord Blood Bank
    Aurora, Colorado 80218
    Leukemia, Lymphoma, Myelodysplastic Syndromes
    A Trial of PDL192 in Subjects With Advanced Solid Tumors
    Site Reference ID/Investigator# 53364
    Aurora, Colorado 80045
    Cancer
    A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)
    University of Colorado Health Science Center
    Aurora, Colorado 80010-0510
    Advanced Solid Tumors
    A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies
    University of Colorado Health Science Center
    Aurora, Colorado 80010-0510
    Neoplasms
    Rollover Protocol for Prior SU011248 Protocols
    Pfizer Investigational Site
    Aurora, Colorado 80012
    Solid Tumors
    Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
    GSK Investigational Site
    Aurora, Colorado 80012
    Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
    Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer
    University Colorado Cancer Center
    Aurora, Colorado 80045
    Metastatic Non-small Cell Lung Cancer
    Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas
    University of Colorado Health Science Center
    Aurora, Colorado 80010-0510
    Malignant Gliomas
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    The Medical Center of Aurora
    Aurora, Colorado 80012
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes